Genetic analysis of canine parvovirus vaccine strains in Korea
2009
Yang, D.K., National Veterinary Research and Quarantine Service, Anyang, Republic of Korea | Kim, B.H., National Veterinary Research and Quarantine Service, Anyang, Republic of Korea | Kim, Y.H., National Veterinary Research and Quarantine Service, Anyang, Republic of Korea | Lee, K.W., National Veterinary Research and Quarantine Service, Anyang, Republic of Korea | Choi, S.S., National Veterinary Research and Quarantine Service, Anyang, Republic of Korea | Son, S.W., National Veterinary Research and Quarantine Service, Anyang, Republic of Korea
After the original identification of canine parvovirus (CPV) type 2 (CPV-2) in 1978, new antigenic variants such as CPV-2a, CPV-2b and CPV-2c have become widespread in the most countries. In this study, the genetic analysis of canine parvovirus was investigated in a total of 13 CPV vaccines, which have been licensed in Korea since late 1980s, and a field isolate of CPV from a dog with CPV infection clinical symptom. The partial VP2 gene of CPV was amplified and sequenced from 13 vaccine strains and one field isolate. The results showed that of the 13 vaccine strains, 10 strains belong to the CPV-2, 2 strains to CPV-2b, the remaining and one isolate to CPV-2a type, respectively. Several mutations of amino acids were detected at residues of the critical region of the commercial vaccine strains. These data suggest that new type of vaccines containing CPV-2a or CPV-2b/2c type may be required for the better prevention of new CPV infection in dog population in Korea, because CPV-2 contained in most licensed vaccines has been replaced by antigenic variants designated CPV-2a or CPV-2b/c in the worldwide dog population.
Show more [+] Less [-]AGROVOC Keywords
Bibliographic information
This bibliographic record has been provided by Korea Agricultural Science Digital Library
